Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Altimmune (ALT) EBT Margin (2016 - 2025)

Altimmune (ALT) has disclosed EBT Margin for 16 consecutive years, with 222653.85% as the latest value for Q4 2025.

  • Quarterly EBT Margin fell 108176615.0% to 222653.85% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 8600.0% through Dec 2025, up 2469000.0% year-over-year, with the annual reading at 8600.0% for FY2025, 2469000.0% up from the prior year.
  • EBT Margin for Q4 2025 was 222653.85% at Altimmune, up from 380280.0% in the prior quarter.
  • The five-year high for EBT Margin was 1304420.0% in Q4 2024, with the low at 1185650.0% in Q3 2022.
  • Average EBT Margin over 5 years is 151942.31%, with a median of 89494.32% recorded in 2022.
  • The sharpest move saw EBT Margin crashed -116444114bps in 2022, then skyrocketed 121237676bps in 2024.
  • Over 5 years, EBT Margin stood at 1669.03% in 2021, then tumbled by -5091bps to 83307.69% in 2022, then surged by 210bps to 92043.24% in 2023, then surged by 1317bps to 1304420.0% in 2024, then plummeted by -83bps to 222653.85% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 222653.85%, 380280.0%, and 442920.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.